AbbVie Gets Humira Patent Invalidated As Obvious
AbbVie Inc. has won a ruling in New York federal court declaring invalid a patent for the anti-inflammatory drug Humira held by the Mathilda and Terence Kennedy Institute of Rheumatology Trust,...To view the full article, register now.
Already a subscriber? Click here to view full article